UK markets open in 52 minutes
NIKKEI 225
38,292.55 -113.11 (-0.29%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.24 -0.69 (-0.84%) GOLD FUTURES
2,298.70 -4.20 (-0.18%) DOW
37,815.92 -570.17 (-1.49%) Bitcoin GBP
47,985.47 -2,738.28 (-5.40%)
JCR Pharmaceuticals Co., Ltd. (4552.T)
Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
At close: 02:47PM JST
Currency in JPY
Valuation measures4
| Market cap (intra-day) | 101.71B |
| Enterprise value | 106.71B |
| Trailing P/E | 19.06 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.47 |
| Price/book (mrq) | 1.83 |
| Enterprise value/revenue | 2.58 |
| Enterprise value/EBITDA | 14.08 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.01 |
| 52-week change 3 | -44.14% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 1,567.00 |
| 52-week low 3 | 773.00 |
| 50-day moving average 3 | 857.62 |
| 200-day moving average 3 | 1,128.69 |
Share statistics
| Avg vol (3-month) 3 | 703.14k |
| Avg vol (10-day) 3 | 495.27k |
| Shares outstanding 5 | 124.8M |
| Implied shares outstanding 6 | 127.95M |
| Float 8 | 73.38M |
| % held by insiders 1 | 43.26% |
| % held by institutions 1 | 16.56% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 20 |
| Forward annual dividend yield 4 | 2.45% |
| Trailing annual dividend rate 3 | 20.00 |
| Trailing annual dividend yield 3 | 2.45% |
| 5-year average dividend yield 4 | 0.90 |
| Payout ratio 4 | 46.76% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 28 Mar 2024 |
| Last split factor 2 | 4:1 |
| Last split date 3 | 30 Sept 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Mar 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 12.97% |
| Operating margin (ttm) | 9.64% |
Management effectiveness
| Return on assets (ttm) | 5.03% |
| Return on equity (ttm) | 9.93% |
Income statement
| Revenue (ttm) | 41.37B |
| Revenue per share (ttm) | 331.61 |
| Quarterly revenue growth (yoy) | -15.00% |
| Gross profit (ttm) | N/A |
| EBITDA | 9.87B |
| Net income avi to common (ttm) | 5.36B |
| Diluted EPS (ttm) | 42.79 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 18.3B |
| Total cash per share (mrq) | 146.64 |
| Total debt (mrq) | 23.3B |
| Total debt/equity (mrq) | 41.65% |
| Current ratio (mrq) | 1.80 |
| Book value per share (mrq) | 445.92 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.